Navigation Links
Drug Regulators Need To Think In Long-Term, Say Charities

Medical charities have urged drug regulators in Scotland to think in terms of long-term benefit before deciding which drugs are expensive and which are not. //

Clara MacKay, of Breast Cancer Care Scotland cited the example of some women needing to take legal recourse for getting Herceptin, the breast cancer drug. "The perception is that those wanting Herceptin are taking away resources. They were demonized for trying to access treatment. Meanwhile the overall picture is ignored," she said.

Herceptin costs approximately £20,000 per year per patient and it is estimated that only around 300 women will receive the drug after costs, which will come up to almost £7.7 million. Mark Hazelwood, director of the Multiple Sclerosis Society Scotland, said that patients should be taken into confidence before any decisions were made.

"Patients don't see access to drugs in isolation. They see the total picture. Drug companies want to rush things through and get a patent but MS is lifelong. We need to capture health costs not just in payment but in its impact on society," he said.


'"/>




Page: 1

Related medicine news :

1. A brush with the U.S. Regulators can cost a fortune
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Regulators Object Drug Produced from Genetically Engineered Farm Animals
4. Australian Drug Regulators Call for Revamp On The Pharmaceutical Surveillance
5. European Regulators Investigate Common Painkiller Drugs
6. Canadian Regulators allow Silicone Breast Implants in Market
7. New Study Challenges How Regulators Determine Risk
8. Researchers Urge Regulators to Rethink Strategies for Soot Emission
9. Positive Thinking
10. Thinking Could Be Affected Due To Hormone Therapy
11. US Thinks About The Alternative Methods To Combat Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... Utah (PRWEB) , ... May 06, 2016 , ... ... Step, an online provider of career-focused education and corporate training, and the National ... are pleased to announce Maritza Aquino as the second full-tuition scholarship recipient of ...
(Date:5/5/2016)... ... 2016 , ... TransWipe Volume 3 is a set of 30 professional transition ... preset between two video clips to instantly add a unique transition to any Final ... color and orientation options. TransWipe Volume 3 is a Final Cut Pro X exclusive ...
(Date:5/5/2016)... ... May 05, 2016 , ... The ... electronic cigarettes, requiring e-cigarette manufacturers to submit their products through an arduous federal ... all vaping products that entered the market since February 15, 2007. That would ...
(Date:5/5/2016)... SAN FRANCISCO (PRWEB) , ... May 05, 2016 ... ... in the Unites States to promise successful results with IVF and with egg ... Designed to deliver the most patient-centric and highest quality fertility care, Spring Fertility ...
(Date:5/5/2016)... ... ... Derrin Doty Group has unveiled the latest charity campaign in their ongoing ... Seattle. The insurance provider’s caring team has been so moved by the sudden death ... from the flu, that they have decided to extend their original campaign. Compassionate community ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 According to market ... and Demand Forecast to 2022 - Industry Insights by Slice ... Center and Others)" by P&S Market Research, the global ... 2015, and it is expected to grow at a CAGR ... slice type segment is expected to witness the faster growth, ...
(Date:5/4/2016)... D.C. , May 4, 2016 ... member companies concluded a series of free workshops ... in global requirements for Good Distribution ... of quality assurance which ensures that products are consistently stored, ... the marketing authorization (MA) or product specification. Only a ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Multiple Myeloma Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Myeloma epidemiology, Multiple Myeloma market valuations and ...
Breaking Medicine Technology: